Susquehanna International Group
MIRA icon

Susquehanna International Group’s MIRA Pharmaceuticals MIRA Stock Holding History

Susquehanna International Group’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.9K Buy
+25,146
New +$31.5K ﹤0.01% 12793
2024
Q2 		– Sell
-15,573
Closed -$17.1K – 12787
2024
Q1 		$17.1K Buy
+15,573
New +$16.9K ﹤0.01% 11850

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's MIRA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in MIRA Pharmaceuticals (MIRA) in Q1 2026: 25,146 shares worth $26.9K. The stake represents ﹤0.01% of the portfolio and ranks #12793 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MIRA as recently as Q1 2024.

Susquehanna International Group first reported a position in MIRA in Q1 2024 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Susquehanna International Group held 25,146 shares of MIRA Pharmaceuticals worth $26.9K as of Q1 2026.
  • MIRA Pharmaceuticals was a new Susquehanna International Group position in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12793 holding.
  • Susquehanna International Group first reported a position in MIRA Pharmaceuticals in Q1 2024 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.